Timothy Daley
Stock Analyst at Wells Fargo
(2.02)
# 3,049
Out of 5,124 analysts
58
Total ratings
54.29%
Success rate
1.11%
Average return
Main Sectors:
Stocks Rated by Timothy Daley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Initiates: Equal-Weight | $47 | $45.19 | +3.30% | 1 | Dec 19, 2023 | |
| MYGN Myriad Genetics | Initiates: Equal-Weight | $20 | $6.14 | +225.73% | 1 | Dec 19, 2023 | |
| RVTY Revvity | Initiates: Equal-Weight | $95 | $98.15 | -3.21% | 1 | Dec 19, 2023 | |
| BRKR Bruker | Initiates: Equal-Weight | $72 | $48.11 | +49.66% | 1 | Dec 19, 2023 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $145 | $137.95 | +5.11% | 5 | Nov 22, 2023 | |
| MTD Mettler-Toledo International | Maintains: Overweight | $1,520 → $1,300 | $1,411.39 | -7.89% | 5 | Nov 13, 2023 | |
| WAT Waters | Maintains: Equal-Weight | $305 → $285 | $381.96 | -25.38% | 5 | Nov 8, 2023 | |
| DHR Danaher | Maintains: Overweight | $285 → $247 | $230.40 | +7.20% | 3 | Oct 3, 2023 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $280 → $275 | $202.42 | +35.86% | 4 | Sep 22, 2023 | |
| LH Labcorp Holdings | Maintains: Overweight | $290 → $270 | $251.66 | +7.29% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $28 | $7.00 | +300.00% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $35 | $20.58 | +70.07% | 6 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $505 → $520 | $592.51 | -12.24% | 3 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $0.54 | +1,575.98% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $185 | $164.35 | +12.56% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $80 → $85 | $74.56 | +14.00% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $235 → $220 | $225.37 | -2.38% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $245 → $220 | $188.67 | +16.61% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $28 | $11.46 | +144.33% | 4 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $135 → $140 | $173.79 | -19.44% | 2 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $90 | $59.65 | +50.88% | 3 | Jan 10, 2023 |
Qiagen
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $47
Current: $45.19
Upside: +3.30%
Myriad Genetics
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $20
Current: $6.14
Upside: +225.73%
Revvity
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $95
Current: $98.15
Upside: -3.21%
Bruker
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $72
Current: $48.11
Upside: +49.66%
Agilent Technologies
Nov 22, 2023
Maintains: Overweight
Price Target: $160 → $145
Current: $137.95
Upside: +5.11%
Mettler-Toledo International
Nov 13, 2023
Maintains: Overweight
Price Target: $1,520 → $1,300
Current: $1,411.39
Upside: -7.89%
Waters
Nov 8, 2023
Maintains: Equal-Weight
Price Target: $305 → $285
Current: $381.96
Upside: -25.38%
Danaher
Oct 3, 2023
Maintains: Overweight
Price Target: $285 → $247
Current: $230.40
Upside: +7.20%
Charles River Laboratories International
Sep 22, 2023
Maintains: Overweight
Price Target: $280 → $275
Current: $202.42
Upside: +35.86%
Labcorp Holdings
Aug 14, 2023
Maintains: Overweight
Price Target: $290 → $270
Current: $251.66
Upside: +7.29%
Aug 14, 2023
Maintains: Overweight
Price Target: $22 → $28
Current: $7.00
Upside: +300.00%
Jul 31, 2023
Maintains: Overweight
Price Target: $30 → $35
Current: $20.58
Upside: +70.07%
Jul 28, 2023
Maintains: Underweight
Price Target: $505 → $520
Current: $592.51
Upside: -12.24%
Jul 20, 2023
Initiates: Overweight
Price Target: $9
Current: $0.54
Upside: +1,575.98%
Jul 20, 2023
Initiates: Overweight
Price Target: $185
Current: $164.35
Upside: +12.56%
May 2, 2023
Maintains: Equal-Weight
Price Target: $80 → $85
Current: $74.56
Upside: +14.00%
May 1, 2023
Maintains: Equal-Weight
Price Target: $235 → $220
Current: $225.37
Upside: -2.38%
May 1, 2023
Maintains: Equal-Weight
Price Target: $245 → $220
Current: $188.67
Upside: +16.61%
Feb 8, 2023
Maintains: Overweight
Price Target: $25 → $28
Current: $11.46
Upside: +144.33%
Feb 3, 2023
Maintains: Equal-Weight
Price Target: $135 → $140
Current: $173.79
Upside: -19.44%
Jan 10, 2023
Upgrades: Equal-Weight
Price Target: $90
Current: $59.65
Upside: +50.88%